Loading...

Home
ETF
ARTV

ARTV

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ARTV News

Artiva Biotherapeutics Reports 2025 Financial Results and Pipeline Progress

Mar 11 2026NASDAQ.COM

Artiva Biotherapeutics Reports FY GAAP EPS of -$3.43

Mar 10 2026seekingalpha

Artiva Biotherapeutics Appoints New CFO

Feb 24 2026NASDAQ.COM

NanoSyrinx Appoints New CEO to Advance Nanosyringe Technology

Jan 08 2026Newsfilter

Crude Oil Declines by More Than 1%; US Homebuilder Confidence Rises Slightly in December

Dec 15 2025Benzinga

US Stocks Show Varied Performance as NY Manufacturing Activity Declines in December

Dec 15 2025Benzinga

After-Hours Stock Surge: Exicure Leads with 72% Increase, Followed by Wave Life and Assembly Biosciences

Dec 09 2025NASDAQ.COM

Artiva Biotherapeutics (ARTV) Soars 113.9% Following FDA Fast Track Designation for AlloNK in Refractory RA – Is the Bullish Outlook Still Valid?

Oct 19 2025Yahoo Finance

Friday's Major Stock Market Highlights: Morning News Summary!

Oct 17 2025TipRanks

What’s Behind the 105% Surge in Artiva Biotherapeutics Stock (ARTV) Today?

Oct 17 2025TipRanks

Most Active Stocks in Pre-Market on October 17, 2025: BITF, SQQQ, ARTV, IONZ, TSLL, CREV, NIO, GWH, BBAI, IONQ, QBTS, LAC

Oct 17 2025NASDAQ.COM

Needham Affirms Buy Rating for Artiva Biotherapeutics, Keeps $18 Price Target Intact

Oct 17 2025Benzinga

Artiva (ARTV) Q2 Loss Widens 19.7%

Aug 07 2025NASDAQ.COM

ArrePath Announces Closing of Their Next Financing Round and Appointment of a New Board Chair

Jun 24 2025Newsfilter

Artiva Biotherapeutics to Present Longer-term Phase 1/2 Data for AlloNK® in Combination with Rituximab in Patients with B-cell-Non-Hodgkin Lymphoma at the ASGCT 28th Annual Meeting

Apr 28 2025Newsfilter

Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer

Apr 08 2025Newsfilter